Ş. CANLAR Et Al. , "What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?," ECE 2017 , 2017
CANLAR, Ş. Et Al. 2017. What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?. ECE 2017 .
CANLAR, Ş., KESKİN, Ç., GÖKÇAY CANPOLAT, A., GÜLLÜ, S., & ÇORAPÇIOĞLU, D., (2017). What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission? . ECE 2017
CANLAR, ŞULE Et Al. "What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?," ECE 2017, 2017
CANLAR, ŞULE Et Al. "What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?." ECE 2017 , 2017
CANLAR, Ş. Et Al. (2017) . "What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?." ECE 2017 .
@conferencepaper{conferencepaper, author={ŞULE CANLAR Et Al. }, title={What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?}, congress name={ECE 2017}, city={}, country={}, year={2017}}